Effect of the consumption of a cheese enriched with probiotic organisms (Bifidobacterium lactis Bi-07) in improving symptoms of constipation;Efeito da ingestão de um queijo acrescido de microrganismos probióticos (Bifidobacterium lactis Bi-07) na melhora de sintomas de constipação

Arquivos de Gastroenterologia

Volumn 50, Issue 3, 2013, Pages 196-201

  Favretto, Diane Cássia ^a   Pontin, Bruna ^b   Moreira, Thaís Rodrigues ^c  

^a CENTRO UNIVERSITÁRIO UNIVATES   (Brazil)

^b INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bifdobacterium; Cheese; Constipation; Probiotics

Indexed keywords

BIFIDOBACTERIUM ANIMALIS EXTRACT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BODY MASS; CHEESE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; FEMALE; HUMAN; NONHUMAN; NUTRITIONAL VALUE; OBESITY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BIFIDOBACTERIUM; CASE-CONTROL STUDIES; CHEESE; CONSTIPATION; FEMALE; HUMANS; MIDDLE AGED; PROBIOTICS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885084856     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032013000200035     Document Type: Article

References (27)

1. Adibi P, Behzad E, Pirzadeh S, Mohseni M. Bowel habit reference values and abnormalities in young Iranian healthy adults. Dig Dis Sci. 2007;52:1810-1813.
2. Amenta M, Cascio MT, Di Fiore, P, Venturini I. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifdobacterium longum W11 + FOS Actilight). Acta Biomed. 2006;77:157-162.
3. Arce DA, Ermocilla CA, Costa H. Evaluation of constipation. Am Fam Physician. 2002;65:2283-2290.
4. Cáceres P, Gotteland M. Alimentos probióticos en Chile: ¿Qué cepas y que propiedades saludables? Rev Chil Nutr. 2010;37:97-109. doi: 10.4067/S0717-75182010000100010.
5. Cisternas CD. El uso de probióticos en el síndrome de intestino irritable y con-stipación. Acta Gastroenterol Latinoam. 2010;21:257-259.
6. Collete VL, Araújo CL, Madruga SW. Prevalência e fatores associados à con-stipação intestinal: um estudo de base populacional em Pelotas, Rio Grande do Sul, Brasil, 2007. Cad Saúde Pública. 2010;26:1391-1402. doi: 10.1590/S0102-311X2010000700018.
7. Corazziari E. Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2004;18:613-631.
8. De Paula JA, Camuega E, Weill R. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam. 2008;38:16-25.
9. Dennison C, Prasad M, Lloyd A, Bhattacharyya SK, Dhawan R, Coyne K. The health-related quality of life and economic burden of constipation. Pharmacoeco-nomics. 2005;23:461-476.
10. Foxx-Orestein AE, McNally MA, Odunsi ST. Update on constipation: one treatment does not ft all. Cleve Clin J Med. 2008;75:813-824.
11. Gerritsen J, Rijkers GT, Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011;6:209-240.
12. Gotteland M, Vizcarra M, Maury E. Efecto de un product lácteo con probióticos e prebióticos sobre La funcion digestiva de sujetos sanos y constipados. Rev Chil Nutr. 2010;37:340-351. doi: 10.4067/S0717-75182010000300009.
13. Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C. Effect of a fermented milk containing Bifdobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in aduts in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther. 2007;26:475-486.
14. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750-759.
15. Instituto Nacional de Câncer [Internet]. Incidência de câncer no Brasil, 2012. [cited 2012 Apr 23]. Available from: http://www.inca.gov.br/estimativa/2012.
16. Lewis SJ, Heaton KW. The metabolic consequences of slow colonic transit. Am J Gastroenterol. 1999;94:2010-2016.
17. Locke GR 3rd, Pemberton JH, Phillips SF. AGA technical review on constipation. American Gastroenterological Association. Gastroenterology. 2000;119:1766-1778.
18. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.
19. Mollen RM, Claassen AT, Kuijpers JH. The evaluation and treatment of functional constipation. Scand J Gastroenterol Suppl. 1997; 223:8-17.
20. Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol. 2008;8:5.
21. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
22. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C: Review article: bifdobacteria as probiotic agents - physiological effects and clinical benefts. Aliment Pharmacol Ther. 2005;22:495-512.
23. Román JL, Gonzálvez ABM, Luque A, Minãno JAP, Acosta AV, Iglesias JR, Hernández M, Villegas JA. Efecto de la ingesta de un preparado lácteo con fbra dietética sobre El estreñimiento crónico primario idiopático. Nutr Hosp. 2008;23:12-19.
24. Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of effcacy. J Pediatr Gastro-enterol Nutr. 2006;42:454-475.
25. Tack J, Müller-Lissner S. Treatment of chronic constipation: current pharmacological approaches and future directions. Clin Gastroenterol Hepatol. 2009;7:502-508.
26. World Gastroenterology Organisation Practice Guidelines Constipation [Internet]. Constipação: uma perspectiva mundial, 2010. [cited 2012 Apr 25] Available from: http://www.worldgastroenterology.org/assets/export/userfles/constipa-tion_pt.pdf.
27. Yang YX, He M, Hu G, Wei J, Pages P, Yang XH, Bourdu-Naturel S. Effect of a fermented milk containing Bifdobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol. 2008;14:6237-6243.